Kernal Biologics

Cambridge, United States

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

$48.0M raised

Oct 2025

Grant

Biotechnology Pharmaceutical Therapeutics

Top Investors

Y CombinatorGaingelsHummingbird VenturesHOF CapitalThe Boeing Company

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kernal Biologics

How much funding has Kernal Biologics raised?

Kernal Biologics has raised $48.0M in total funding. The most recent round was Grant. The last funding was announced in October 2025.

Who are Kernal Biologics's investors?

Kernal Biologics's investors include Y Combinator, Gaingels, Hummingbird Ventures, HOF Capital, The Boeing Company.

Where is Kernal Biologics headquartered?

Kernal Biologics is headquartered in Cambridge, United States.

What does Kernal Biologics do?

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

What stage is Kernal Biologics at?

Kernal Biologics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 7, 2025.

MLA

"Kernal Biologics — Funding & Investors." VCBacked, October 7, 2025, https://www.vcbacked.co/company/kernal-biologics. Accessed July 1, 2026.

APA

VCBacked. (2025). Kernal Biologics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/kernal-biologics

Wikipedia (cite web)

{{cite web |title=Kernal Biologics — Funding & Investors |url=https://www.vcbacked.co/company/kernal-biologics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 7, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K